Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,101,896
+$309,883 QoQ
Shares Held
31,901
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#1,240
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $47,881,370 across 14 Drug Manufacturers - General names. JNJ ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,223 | $8,663,483 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
31,901 | $8,101,896 | |
| 3 | ABBV |
AbbVie Inc.
|
27,419 | $6,899,717 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,521 | $6,363,448 | |
| 5 | AMGN |
Amgen Inc
|
14,656 | $5,307,230 | |
| 6 | PFE |
Pfizer Inc
|
168,925 | $4,067,714 | |
| 7 | AZN |
Astrazeneca PLC
|
15,469 | $2,933,231 | |
| 8 | SNY |
Sanofi
|
46,110 | $1,967,052 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,101,896 | 31,901 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $7,792,013 | 31,877 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $7,487,451 | 36,180 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $7,069,322 | 38,126 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $6,677,008 | 43,712 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $7,825,989 | 47,190 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $6,551,141 | 45,299 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,371,785 | 45,488 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $5,409,089 | 37,008 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $6,505,721 | 41,126 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $10,145,153 | 64,726 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $9,970,492 | 64,016 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $9,859,364 | 59,566 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $9,158,485 | 59,087 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $10,365,292 | 58,677 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $9,738,216 | 59,612 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $10,295,224 | 57,998 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $11,595,095 | 65,424 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $10,142,056 | 59,286 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $9,469,391 | 58,634 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,721,472 | 59,011 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $9,216,583 | 56,079 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $8,464,053 | 53,781 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,666,426 | 51,494 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $7,207,146 | 51,249 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $7,201,397 | 54,918 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||